Rituximab-Associated Progressive Multifocal Leukoencephalopathy: A Twenty-Year Update.

Bennett, Charles L; Witherspoon, Bartlett; Carson, Kenneth R

Bennett, Charles L; Witherspoon, Bartlett; Carson, Kenneth R.

Afiliación

Bennett CL; SONAR (Southern Network on Adverse Reactions) Program, University of South Carolina College of Pharmacy, Columbia, SC, 29208, USA.
Witherspoon B; SONAR (Southern Network on Adverse Reactions) Program, University of South Carolina College of Pharmacy, Columbia, SC, 29208, USA.
Carson KR; SONAR (Southern Network on Adverse Reactions) Program, University of South Carolina College of Pharmacy, Columbia, SC, 29208, USA. Kenneth_R_Carson@rush.edu.

Cancer Treat Res ; 184: 103-111, 2022.

Article en En | MEDLINE | ID: mdl-36449191

Asunto(s)

Leucoencefalopatía Multifocal Progresiva; Humanos; Leucoencefalopatía Multifocal Progresiva/inducido químicamente; Rituximab/efectos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucoencefalopatía Multifocal Progresiva Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Treat Res Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google